Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews · Musculoskeletal

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Withdrawals due to adverse events · acute gout

Canakinumab showed no clear difference in study withdrawals due to AE (all canakinumab doses) compared with triamcinolone acetonide (low certainty).

1 finding from 1 review

Interleukin‐1 inhibitors for acute gout 2014 · Cochrane Headline outcomes only
RR 1.07 [0.16, 7.23]
3 studies · 654 participants
Low